Why Is Horizon Therapeutics (HZNP) Up 3.7% Since Last Earnings Report?Zacks Investment Research • 09/03/21
Horizon Therapeutics Public Limited Company (HZNP) CEO Tim Walbert on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
Horizon Therapeutics Stock Shoots Higher As Relaunch Of Thyroid Eye Disease Med Boosts Q2 Sales; Raises FY21 OutlookBenzinga • 08/04/21
Horizon Therapeutics (HZNP) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/04/21
Horizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA GuidanceBusiness Wire • 08/04/21
Horizon Therapeutics (HZNP) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/28/21
Fortune Names Horizon Therapeutics One of the 2021 Best Workplaces for Millennials™Business Wire • 07/16/21
Horizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021Business Wire • 07/08/21
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating HZN-7734 for the Treatment of Systemic Lupus ErythematosusBusiness Wire • 06/29/21
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled GoutBusiness Wire • 06/21/21
Horizon Therapeutics plc Announces Multiple Presentations on Neuromyelitis Optica Spectrum Disorder (NMOSD) at the 7th Congress of the European Academy of Neurology (EAN)Business Wire • 06/18/21
Horizon Therapeutics plc Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline BiologicsBusiness Wire • 06/17/21
Horizon Therapeutics (HZNP) Down 1.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/04/21
Horizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of RheumatologyBusiness Wire • 06/02/21
Horizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA MonotherapyBusiness Wire • 05/27/21